Efficacy and tolerability of olanzapine long-acting injection and oral olanzapine as maintenance therapy in patients with schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2011
At a glance
- Drugs Olanzapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 05 Nov 2011 Results presented at the 14th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
- 05 Nov 2010 New trial record.